Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Genitourinary 1CNS 1

Conditions

Wilms Tumor 2Testicular Neoplasms 2Sarcoma, Ewing 2Sarcoma 2Rhabdomyosarcoma 2Neuroblastoma 2Medulloblastoma 2Kidney Neoplasms 2Brain Neoplasms 2Astrocytoma 2Teratoma 1Retinoblastoma 1Prostatic Neoplasms 1Ovarian Neoplasms 1Ovarian Germ Cell Cancer 1Optic Nerve Glioma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroectodermal Tumors 1Neoplasms, Plasma Cell 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma 1Liver Neoplasms 1Leukemia 1Hepatoblastoma 1Glioma 1Familial ependymoma 1Ependymoma 1Desmoplastic Small Round Cell Tumor 1Chordoma 1

Interventions

Filgrastim 4Temozolomide 3Carboplatin 3Peripheral Blood Stem Cell Transplantation 2Oxaliplatin 2Melphalan 2Ifosfamide 2Granulocyte Colony-Stimulating Factor 2Etoposide 2Busulfan 2trioctyl phosphine oxide 1sargramostim 1palbociclib 1olaparib 1ixabepilone 1etoposide phosphate 1erdafitinib 1alvocidib 1X-Rays 1Transplantation 1Topotecan 1Thiotepa 1Stem Cell Transplantation 1Specimen Handling 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Psychiatric Rehabilitation 1Phantoms, Imaging 1PT-100 dipeptide 1O(6)-benzylguanine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Familial ependymoma × Bone Marrow Transplantation × Genitourinary × Clear all
NCT00638898 2025-03-20

Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor

City of Hope Medical Center

Phase 1 Completed
25 enrolled
CNSGenitourinarySarcoma

Familial ependymoma, Astrocytoma, Brain Neoplasms, Medulloblastoma, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Testicular Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral, Optic Nerve Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡